Selling And Administration Expenses Endring Dato
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Adma Biologics USD 16.22M 1.03M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
AstraZeneca USD 3.91B 194M 2023-09
BioCryst Pharmaceuticals USD 50.65M 349K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Cipla INR 10.91B 245.2M 2023-09
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.29M 163K 2023-09
CSL USD 1.29B 219.4M 2023-06
Dynavax Technologies USD 39.79M 2.63M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Esperion Therapeutics USD 33.24M 719K 2023-09
GlaxoSmithKline GBP 2.18B 6M 2023-09
Grifols EUR 300.32M 28.7M 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
J&J USD 5.81B 410M 2023-12
Marinus Pharmaceuticals USD 14.87M 854K 2023-09
Merck USD 2.75B 272M 2023-12
Minerva Neurosciences USD 2.64M 3.06K 2023-09
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Novavax USD 107.46M 25.24M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Takeda JPY 252.95B 4.84B 2023-09
Vanda Pharmaceuticals USD 28.4M 7.7M 2023-06



Minerva Neurosciences Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.